According to recent reports, the incidence of type 1 diabetes has been increasing throughout the globe at rates ranging from 3 to 5 percent a year as researchers struggle to determine a cause.1
We asked Dr. Matthias von Herrath, the head of Novo Nordisk’s new diabetes research center in Seattle, to share his thoughts on the rise in type 1 diabetes and the biggest challenges in researching the disease.